| P2093 | author name string | Haiyan Zhang | |
| | Hua Jin | |
| | Fen Huang | |
| | Zhiping Fan | |
| | Yanqiu Chen | |
| | Qifa Liu | |
| | Yuan Suo | |
| | Kaibo Yang | |
| | Yiling Ye | |
| | Hanzhou Qi | |
| P2860 | cites work | Autoantigen Ro52 is an E3 ubiquitin ligase | Q24296239 |
| | Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission | Q24539030 |
| | The clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to man | Q26825196 |
| | TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved | Q27650357 |
| | Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects | Q33555784 |
| | Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans | Q33781179 |
| | A blast from the past: clearance of apoptotic cells regulates immune responses. | Q34162195 |
| | Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors | Q34312702 |
| | Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease | Q34707354 |
| | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report | Q35085226 |
| | Aberrant B-cell homeostasis in chronic GVHD | Q35171251 |
| | Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans. | Q35607308 |
| | Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden | Q35620360 |
| | Risk factors for acute GVHD and survival after hematopoietic cell transplantation | Q35651735 |
| | Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans | Q35776453 |
| | Rituximab for steroid-refractory chronic graft-versus-host disease | Q35848933 |
| | Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies | Q36173285 |
| | A 52-kD protein is a novel component of the SS-A/Ro antigenic particle | Q36354952 |
| | Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases | Q36439998 |
| | Confounding B-cell defences: lessons from a staphylococcal superantigen | Q36488759 |
| | H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease | Q36637621 |
| | Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia | Q36822659 |
| | Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice. | Q36876981 |
| | Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease. | Q37104281 |
| | Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease | Q37162874 |
| | Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway | Q37292757 |
| | Increased BCR responsiveness in B cells from patients with chronic GVHD. | Q37670076 |
| | Tripartite-motif proteins and innate immune regulation | Q37815984 |
| | The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review | Q37991902 |
| | Ro52 functionally interacts with IgG1 and regulates its quality control via the ERAD system. | Q40049469 |
| | The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death | Q40284365 |
| | B-cell superantigens: definition and potential impact on the immune response | Q40977386 |
| | Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria | Q41180891 |
| | Association of mixed hematopoietic chimerism with elevated circulating autoantibodies and chronic graft-versus-host disease occurrence | Q42152223 |
| | Immunohistochemistry of cutaneous graft-versus-host disease after allogeneic bone marrow transplantation | Q42473873 |
| | The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures | Q42677729 |
| | Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. | Q45998826 |
| | Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease | Q46068682 |
| | Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study | Q46833854 |
| | Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease | Q47402442 |
| | Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations | Q47605536 |
| | SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 production | Q48024882 |
| | Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission. | Q48359012 |
| | B cells in the pathogenesis of primary Sjögren syndrome | Q48507544 |
| | Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets | Q49552733 |
| | B-cell targeting in chronic Graft-versus-Host disease | Q50044417 |
| | Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. | Q51567914 |
| | The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. | Q53632072 |
| | Sjögren’s syndrome | Q56224755 |
| | Small-molecule BCL6 inhibitor effectively treats mice with non-sclerodermatous chronic graft-versus-host disease | Q57044016 |
| | Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy | Q73501402 |
| | Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody | Q73833684 |
| | Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease | Q79961518 |
| | Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease | Q81381423 |
| | Clinical follow-up of 102 anti-Ro/SSA-positive patients with dermatological manifestations | Q81794961 |
| | Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab | Q82048226 |
| | Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody | Q82478447 |
| | HY antibodies as biomarkers for chronic GVHD | Q87315041 |
| | Anti-Angiotensin type 1 receptor antibodies in chronic graft-versus-host disease | Q87976543 |
| | Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party | Q90340390 |
| | A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation | Q91098880 |
| | A multi-centre study for standardization of antinuclear antibody indirect immunofluorescence screening with automated system | Q91204944 |
| | Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study | Q91413924 |
| | Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study | Q91934073 |
| | Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease | Q92056599 |
| | Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease | Q92409553 |
| | Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study | Q92550347 |
| | Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis | Q93062722 |
| | Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation | Q93140219 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1505 | |
| P577 | publication date | 2020-07-28 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation | |
| P478 | volume | 11 | |